Competitive metabolism of L -arginine: Arginase as a therapeutic target in asthma

Journal of Biomedical Research

Volumn 25, Issue 5, 2011, Pages 299-308

  Bratt, Jennifer M ^a   Zeki, Amir A ^a   Last, Jerold A ^a   Kenyon, Nicholas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arginase; L arginine; Nitric oxide; Nitric oxide synthase; Nitrosation; Nor NOHA

Indexed keywords

2 AMINO 5 (2 AMINOIMIDAZOL 1 YL)PENTAENOIC ACID; 2 AMINO 6 BORONOHEXONIC ACID; ANTIASTHMATIC AGENT; ARGINASE; ARGINASE 1; ARGINASE INHIBITOR; ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; S (2 BORONOETHYL)CYSTEINE; S 2 AMINO 6 IODOACETAMIDOHEXANOIC ACID; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; AMINO ACID METABOLISM; ASTHMA; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; INFLAMMATION; NITROSATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 80054864540     PISSN: 16748301     EISSN: 16748301     Source Type: Journal    
DOI: 10.1016/S1674-8301(11)60041-9     Document Type: Review

References (116)

1. Siddiqui S, Martin JG Structural aspects of airway re-modeling in asthma. Curr Allergy Asthma Rep 2008, 8:540-547.
2. Bentley JK, Hershenson MB Airway smooth muscle growth in asthma: proliferation, hypertrophy, and mi-gration. Proc Am Thorac Soc 2008, 5:89-96.
3. Wilson JW, Li X The measurement of reticular base-ment membrane and submucosal collagen in the asth-matic airway. Clin Exp Allergy 1997, 27:363-371.
4. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005, 171:912-930.
5. Singh D, Richards D, Knowles RG, Schwartz S, Wood-cock A, Langley S, et al. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med 2007, 176:988-993.
6. Mabalirajan U, Ahmad T, Leishangthem GD, Joseph DA, Dinda AK, Agrawal A, et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010, 125:626-635.
7. Gaston B, Singel D, Doctor A, Stamler JS S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 2006, 173:1186-1193.
8. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
9. Lipton A, Johnson M, Macdonald T, Lieberman M, Gozal D, Gaston B S-Nitrosothiols signal the ventila-tory response to hypoxia. Nature 2001, 413:171-174.
10. Li D, Shirakami G, Zhan X, Johns RA Regulation of ciliary beat frequency by the nitric oxide-cyclic gua-nosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 2000, 23:175-181.
11. Aizawa H, Takata S, Inoue H, Matsumoto K, Koto H, Hara N Role of nitric oxide released from iNANC neurons in airway responsiveness in cats. Eur Respir J 1999, 3:775-780.
12. Tucker JF, Brave SR, Charalambous L, Hobbs AJ, Gib-son A L-NG-nitroarginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br J Pharmacol 1990, 100:663-664.
13. Kesler BS, Mazzone SB, Canning BJ Nitric Oxide-de-pendent Modulation of Smooth-Muscle Tone by Airway Parasympathetic Nerves. Am J Respir Crit Care Med 2002, 165:481-488.
14. Kubes P, Suzuki M, Granger DN Nitric oxide: an en-dogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991, 88:4651-4655.
15. De Caterina R, Libby P, Peng HB, Thannickal VJ, Ra-javashisth TB, Gimbrone MA, et al. Nitric oxide de-creases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of ad-hesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96:60-68.
16. Bernareggi M, Mitchell JA, Barnes PJ, Belvisi MG Dual action of nitric oxide on airway plasma leakage. Am J Respir Crit Care Med 1997, 155:869-874.
17. Schmidt HW, Walter U NO at work. Cell 1994, 78:919-925.
18. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650.
19. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007, 176:231-237.
20. Mathrani VC, Kenyon NJ, Zeki A, Last JA Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide?. Curr Med Chem 2007, 14:2204-2213.
21. Vercelli D Arginase: marker, effector, or candidate gene for asthma?. J Clin Invest 2003, 111:1815-1817.
22. Kukreja RC, Xi L eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?. J Mol Cell Cardiol 2007, 42:280-282.
23. Guo Z, Shao L, Du Q, Park KS, Geller DA Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. FASEB J 2007, 21:535-542.
24. Marks-Konczalik J, Chu SC, Moss J Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 1998, 273:22201-22208.
25. Chu SC, Marks-Konczalik J, Wu HP, Banks TC, Moss J Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 1998, 248:871-878.
26. Shan J, Carbonara P, Karp N, Tulic M, Hamid Q, Ei-delman DH Localization and distribution of NOS1 in murine airways. Nitric Oxide 2007, 17:25-32.
27. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, et al. Constitutive and inducible nitric ox-ide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 1994, 91:10089-10093.
28. Bratt JM, Williams K, Rabowsky MF, Last MS, Franzi LM, Last JA, et al. Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 ex-pression is NOS3 dependent. Mediators Inflamm 2010, PMID:20953358.
29. Liu X, Miller MJ, Joshi MS, Thomas DD, Lancaster JR Accelerated reaction of nitric oxide with O2 with in hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 1998, 95:2175-2179.
30. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, et al. Nitrite potently inhibits hy-poxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidore-ductase-dependent nitric oxide generation. Circulation 2010, 121:98-109.
31. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, et al. Deoxymyoglobin is a nitrite re-ductase that generates nitric oxide and regulates mito-chondrial respiration. Circ Res 2007, 100:654-661.
32. Gladwin MT, Kim-Shapiro DB The functional nitrite reductase activity of the heme-globins. Blood 2008, 112:2636-2647.
33. Cynober L Pharmacokinetics of arginine and related amino acids. J Nutr 2007, 137:1646S-1649S.
34. Rawal N, Rajpurohit R, Lischwe MA, Williams KR, Paik WK, Kim S Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltrans-ferases. Biochim Biophys Acta 1995, 1248:11-18.
35. Cantoni GL Biological methylation: Selected aspects. Annu Rev Biochem 1975, 44:435-451.
36. MacAllister RJ, Fickling SA, Whitley GS, Vallance P Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 1994, 112:43-48.
37. Vieira RP, Duarte AC, Claudino RC, Perini A, Santos AB, Moriya HT, et al. Creatine supplementation exacer-bates allergic lung inflammation and airway remodeling in mice. Am J Respir Cell Mol Biol 2007, 37:660-667.
38. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by de-carboxylation of arginine. Biochem J 1996, 316:247-249.
39. Xiang YY, Wang S, Liu M, Hirota JA, Li J, Ju W, et al. A GABAergic system in airway epithelium is es-sential for mucus overproduction in asthma. Nat Med 2007, 13:862-867.
40. Sackesen C, Ercan H, Dizdar E, Soyer O, Gumus P, Tosun BN, et al. A comprehensive evaluation of the en-zymatic and nonenzymatic antioxidant systems in child-hood asthma. J Allergy Clin Immunol 2008, 122:78-85.
41. Li H, Meininger CJ, Hawker JR, Haynes TE, Kepka-Lenhart D, Mistry SK, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 2001, 280:E75-E82.
42. Grody WW, Dizikes GJ, Cederbaum SD Human argin-ase isozymes. Curr Top Biol Med Res 1987, 13:181-214.
43. Agostinelli E, Marques MP, Calheiros R, Gil FP, Tem-pera G, Viceconte N, et al. Polyamines: fundamen-tal characters in chemistry and biology. Amino Acids 2010, 38:393-403.
44. Lau T, Owen W, Yu YM, Noviski N, Lyons J, Zura-kowski D, et al. Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 2000, 105:1217-1225.
45. Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F Arginine, citrulline and nitric oxide metabo-lism in sepsis. Clin Sci (Lond) 2009, 117:23-30.
46. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Furst P, Kantrowitz LR, et al. Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg 1980, 192:78-85.
47. Shen LJ, Beloussow K, Shen WC Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem. Pharmacol 2005, 69:97-104.
48. Topal G, Brunet A, Walch L, Boucher JL, David-Dufil-ho M Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther 2006, 318:1368-1374.
49. Closs EI, Scheld JS, Sharafi M, Förstermann U Sub-strate supply for nitric oxide synthase in macrophages and endothelial cells: role of cationic amino acid trans-porters. Mol Pharmacol 2000, 57:68-74.
50. Kenyon NJ, Bratt JM, Linderholm AL, Last MS, Last JA Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences. Toxicol Appl Pharmacol 2008, 230:269-275.
51. Bratt JM, Franzi LM, Linderholm AL, O'Roark EM, Kenyon NJ, Last JA Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol 2010, 242:1-8.
52. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuy-pers FA, Morris SM Decreased arginine bioavailabil-ity and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004, 170:148-153.
53. King NE, Rothenberg ME, Zimmermann N Arginine in asthma and lung inflammation. J Nutr 2004, 134:2830S-2836S.
54. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003, 111:1863-1874.
55. Fajardo I, Svensson L, Bucht A, Pejler G Increased lev-els of hypoxia sensitive proteins in allergic airway in-flammation. Am J Respir Crit Care Med 2004, 170:477-484.
56. Bratt JM, Franzi LM, Linderholm AL, Last MS, Kenyon NJ, Last JA Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice ex-posed to ovalbumin. Toxicol Appl Pharmacol 2009, 234:273-280.
57. Takahashi N, Ogino K, Takemoto K, Hamanishi S, Wang DH, Takigawa T, et al. Direct inhibition of ar-ginase attenuated airway allergic reactions and inflam-mation in a Dermatophagoides farinae-induced NC/Nga mouse model. Am J Physiol Lung Cell Mol Physiol 2010, PMID: 20382750.
58. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 1996, 93:6770-6774.
59. Xia Y, Tsai AL, Berka V, Zweier JL Superoxide gen-eration from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regula-tory process. J Biol Chem 1998, 273:25804-25808.
60. Sullivan JC, Pollock JS Coupled and Uncoupled NOS: Separate But Equal? Uncoupled NOS in Endothelial Cells Is a Critical Pathway for Intracellular Signaling. Circ Res 2006, 98:717.
61. Yoneyama H, Yamamoto A, Kosaka H Neuronal nitric oxide synthase generates superoxide from the oxygenase domain. Biochem J 2001, 360:247-253.
62. Xia Y, Zweier JL Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophag-es. Proc Natl Acad Sci U S A 1997, 94:6954-6958.
63. Xia Y, Roman LJ, Masters BS, Zweier JL Inducible nitric-oxide synthase generates superoxide from the re-ductase domain. J Biol Chem 1998, 273:22635-22639.
64. Niese KA, Collier AR, Hajek AR, Cederbaum SD, O'Brien WE, Wills-Karp M, et al. Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol 2009, 10:33.
65. Klasen S, Hammermann R, Fuhrmann M, Lindemann D, Beck KF, Pfeilschifter J, et al. Glucocorticoids inhibit li-popolysaccharideinduced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001, 132:1349-1357.
66. Lindemann D, Racké K Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:546-550.
67. Takemoto K, Ogino K, Shibamori M, Gondo T, Hitomi Y, Takigawa T, et al. Transiently, paralleled upregulation of arginase and nitric oxide synthase and the ef-fect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1419-L1426.
68. Reczkowski RS, Ash DE Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch Biochem Biophys 1994, 312:31-37.
69. Shen LJ, Beloussow K, Shen WC Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol 2005, 69:97-104.
70. Topal G, Brunet A, Walch L, Boucher JL, David-Dufil-ho M Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther 2006, 318:1368-1374.
71. Closs EI, Scheld JS, Sharafi M, Förstermann U Sub-strate supply for nitric oxide synthase in macrophages and endothelial cells: role of cationic amino acid trans-porters. Mol Pharmacol 2000, 57:68-74.
72. Jiang J, George SC Modeling gas phase nitric ox-ide release in lung epithelial cells. Nitric Oxide 2011, 10.1016/j.niox.2011.04.010.
73. McDonald KK, Zharikov S, Block ER, Kilberg MS A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the arginine paradox. J Biol Chem 1997, 272:31213-31216.
74. Greene B, Pacitti AJ, Souba WW Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol 1993, 264:L351-L356.
75. de Boer J, Meurs H, Coers W, Koopal M, Bottone AE, Visser AC, et al. Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br J Pharmacol 1996, 119:1109-1116.
76. Ricciardolo FL, Di Maria GU, Mistretta A, Sapienza MA, Geppetti P Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet 1997, 350:1297-1298.
77. de Boer J, Duyvendak M, Schuurman FE, Pouw FM, Zaagsma J, Meurs H Role of L-arginine in the defi-ciency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br J Pharmacol 1999, 128:1114-1120.
78. Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J Modulation of cholinergic air-way reactivity and nitric oxide production by endog-enous arginase activity. Br J Pharmacol 2000, 130:1793-1798.
79. Maarsingh H, Tio MA, Zaagsma J, Meurs H Argin-ase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res 2005, 6:23.
80. Maarsingh H, Leusink J, Bos IS, Zaagsma J, Meurs H Arginase strongly impairs neuronal nitric oxide-mediat-ed airway smooth muscle relaxation in allergic asthma. Respir Res 2006, 7:6.
81. Maarsingh H, Leusink J, Zaagsma J, Meurs H Role of the L-citrulline/L-arginine cycle in iNANC nerve-me-diated nitric oxide production and airway smooth muscle relaxation in allergic asthma. Eur J Pharmacol 2006, 546:171-176.
82. Hrabák A, Temesi A, Csuka I, Antoni F Inverse relation in the de novo arginase synthesis and nitric oxide production in murine and rat peritoneal macrophages in long-term cultures in vitro. Comp Biochem Physiol B 1992, 103:839-845.
83. Gotoh T, Mori M Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 1999, 144:427-434.
84. Chicoine LG, Paffett ML, Young TL, Nelin LD Argin-ase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L60-L68.
85. Alcorn JF, Ckless K, Brown AL, Guala AS, Kolls JK, Poynter ME, et al. Strain-dependent activation of NF-kappaB in the airway epithelium and its role in aller-gic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2010, 298:L57-L66.
86. Maarsingh H, Pera T, Meurs H Arginase and pulmo-nary diseases. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:171-184.
87. Morris CR Asthma management: reinventing the wheel in sickle cell disease. Am J Hematol 2009, 84:234-241.
88. Morris SM Recent advances in arginine metabolism: Roles and regulation of the arginases. Br J Pharmacol 2009, 157:922-930.
89. Cama E, Shin H, Christianson DW Design of Amino Acid Sulfonamides as Transition-State Analogue Inhibi-tors of Arginase. J Am Chem Soc 2003, 125:13052-13057.
90. Ilies M, Di Costanzo L, North ML, Scott JA, Christian-son DW 2-Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme Human Ar-ginase I. J Med Chem 2010, 53:4266-4276.
91. Colleluori DM, Ash DE Classical and Slow-Binding Inhibitors of Human Type II Arginase. Biochemistry 2001, 40:9356-9362.
92. Kim NN, Cox JD, Baggio RF, Emig FA, Mistry SK, Harper SL, et al. Probing erectile function: S-(2-boronoethyl)-l-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry 2001, 40:2678-2688.
93. Maarsingh H, Zuidhof AB, Bos IS, van Duin M, Bouch-er JL, Zaagsma J, et al. Arginase inhibition protects against allergen-induced airway obstruction, hyperre-sponsiveness, and inflammation. Am J Respir Crit Care Med 2008, 178:565-573.
94. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA Functionally important role for arginase 1 in the air-way hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009, 296:L911-L920.
95. Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, Klein T, et al. Increased arginase activity con-tributes to airway remodelling in chronic allergic asthma. Eur Respir J 2011.
96. Trujillo-Ferrara J, Koizumia G, Munoz O, Joseph-Nath-an P, Yañez R Antitumor effect and toxicity of two new active-site-directed irreversible ornithine decarboxylase and extrahepatic arginase inhibitors. Cancer Letters 1992, 67:193-197.
97. Mayorek N, Naftali-Shani N, Grunewald M Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase ac-tivity. PLoS One 2010, 5:e12715.
98. Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010, 156:335-349.
99. Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zim-mmermann N, Mahalingam S, et al. Inhibition of argi-nase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 2006, 177:5595-5603.
100. Ckless K, Lampert A, Reiss J, Kasahara D, Poynter ME, Irvin CG, et al. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol 2008, 181:4255-4264.
101. Mabalirajan U, Ahmad T, Leishangthem GD, Joseph DA, Dinda AK, Agrawal A, et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010, 125:626-635.
102. Bratt JM, Williams K, Rabowsky MF, Last MS, Franzi LM, Last JA, et al. Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 ex-pression is NOS3 dependent. Mediators Inflamm 2010, PMID:20953358.
103. Ten Broeke R, De Crom R, Van Haperen R, Verweij V, Leusink-Muis T, Van Ark I, et al. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res 2006, 5:58.
104. Kobayashi K, Nishimura Y, Yamashita T, Sataouchi M, Yokoyama M The effect of overexpression of endothe-lial nitric oxide synthase on eosinophilic lung inflam-mation in a murine model. Int Immunopharmacol 2006, 6:1040-1052.
105. Kenyon NJ, Last M, Bratt JM, Kwan VW, O'Roark E, Linderholm A L-Arginine Supplementation and Me-tabolism in Asthma. Pharmaceuticals 2011, 4:187-201.
106. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, et al. L-arginine treatment alters the ki-netics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997, 96:667-675.
107. Jeyabalan G, Klune JR, Nakao A, Martik N, Wu G, Tsung A, et al. Arginase blockade protects against he-patic damage in warm ischemia-reperfusion. Nitric Oxide 2008, 19:29-35.
108. Reid KM, Tsung A, Kaizu T, Jeyabalan G, Ikeda A, Shao L, et al. Liver I/R injury is improved by the argi-nase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol 2007, 292:G512-G517.
109. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou, et al. L-arginine reduces en-dothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg 1995, 60:1275-1281.
110. Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG, et al. Arginase inhibition restores NOS cou-pling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol 2009, 107:1249-1257.
111. Bagnost T, Berthelot A, Bouhaddi M, Laurant P, An-dré C, Guillaume Y, et al. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. J Hypertens 2008, 26:1110-1118.
112. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003, 108:2000-2006.
113. Iniesta V, Gómez-Nieto LC, Corraliza I The inhibition of arginase by N-(omega)-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001, 193:777-784.
114. Iniesta V, Gómez-Nieto LC, Molano I, Mohedano A, Carcelén J, Mirón C, et al. Arginase I induction in mac-rophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002, 24:113-118.
115. Bivalacqua TJ, Burnett AL, Hellstrom WJ, Champion HC Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol 2007, 292:H1340-H1351.
116. Lim HK, Lim HK, Ryoo S, Benjo A, Shuleri K, Miriel V, et al. Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol 2007, 293:H3317-H3324.